[go: up one dir, main page]

AU2007902266A0 - Treatment of virally induced lesions - Google Patents

Treatment of virally induced lesions

Info

Publication number
AU2007902266A0
AU2007902266A0 AU2007902266A AU2007902266A AU2007902266A0 AU 2007902266 A0 AU2007902266 A0 AU 2007902266A0 AU 2007902266 A AU2007902266 A AU 2007902266A AU 2007902266 A AU2007902266 A AU 2007902266A AU 2007902266 A0 AU2007902266 A0 AU 2007902266A0
Authority
AU
Australia
Prior art keywords
treatment
virally induced
induced lesions
lesions
virally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007902266A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peplin Research Pty Ltd
Original Assignee
Peplin Research Pty Ltd
Filing date
Publication date
Application filed by Peplin Research Pty Ltd filed Critical Peplin Research Pty Ltd
Publication of AU2007902266A0 publication Critical patent/AU2007902266A0/en
Priority to JP2010504384A priority Critical patent/JP5497629B2/en
Priority to ES08733422.3T priority patent/ES2564173T3/en
Priority to PCT/AU2008/000596 priority patent/WO2008131491A1/en
Priority to CN2008800196132A priority patent/CN101742996B/en
Priority to AU2008243705A priority patent/AU2008243705B2/en
Priority to US12/598,102 priority patent/US9895334B2/en
Priority to UAA200912129A priority patent/UA98328C2/en
Priority to PL08733422T priority patent/PL2152261T3/en
Priority to MX2009011865A priority patent/MX2009011865A/en
Priority to CA2685473A priority patent/CA2685473C/en
Priority to EP08733422.3A priority patent/EP2152261B1/en
Priority to DK08733422.3T priority patent/DK2152261T3/en
Priority to HRP20160181TT priority patent/HRP20160181T1/en
Priority to KR1020097024861A priority patent/KR101485883B1/en
Priority to HUE08733422A priority patent/HUE028713T2/en
Priority to BRPI0810806-4A2A priority patent/BRPI0810806A2/en
Priority to RU2009144100/15A priority patent/RU2506951C2/en
Priority to HK10102512.3A priority patent/HK1134450B/en
Priority to NZ580702A priority patent/NZ580702A/en
Priority to MYPI20094567A priority patent/MY154484A/en
Priority to SI200831581A priority patent/SI2152261T1/en
Priority to IL201796A priority patent/IL201796A/en
Priority to CY20161100164T priority patent/CY1119269T1/en
Abandoned legal-status Critical Current

Links

AU2007902266A 2007-04-30 2007-04-30 Treatment of virally induced lesions Abandoned AU2007902266A0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SI200831581A SI2152261T1 (en) 2007-04-30 2008-04-30 Treatment of virally induced lesions
DK08733422.3T DK2152261T3 (en) 2007-04-30 2008-04-30 TREATMENT OF virus-induced INJURY
EP08733422.3A EP2152261B1 (en) 2007-04-30 2008-04-30 Treatment of virally induced lesions
PCT/AU2008/000596 WO2008131491A1 (en) 2007-04-30 2008-04-30 Treatment of virally induced lesions
CN2008800196132A CN101742996B (en) 2007-04-30 2008-04-30 Use of ingenol in the preparation of medicines for the treatment of non-cancerous skin lesions
AU2008243705A AU2008243705B2 (en) 2007-04-30 2008-04-30 Treatment of virally induced lesions
US12/598,102 US9895334B2 (en) 2007-04-30 2008-04-30 Treatment of virally induced lesions
ES08733422.3T ES2564173T3 (en) 2007-04-30 2008-04-30 Treatment of virus induced lesions
PL08733422T PL2152261T3 (en) 2007-04-30 2008-04-30 Treatment of virally induced lesions
MX2009011865A MX2009011865A (en) 2007-04-30 2008-04-30 Treatment of virally induced lesions.
CA2685473A CA2685473C (en) 2007-04-30 2008-04-30 Treatment of virally induced lesions
JP2010504384A JP5497629B2 (en) 2007-04-30 2008-04-30 Method for treating virus-induced lesions
UAA200912129A UA98328C2 (en) 2007-04-30 2008-04-30 Treatment of virus-induced cutaneous lesions
RU2009144100/15A RU2506951C2 (en) 2007-04-30 2008-04-30 Treating virus-induced injuries
KR1020097024861A KR101485883B1 (en) 2007-04-30 2008-04-30 Treatment of virally induced lesions
HUE08733422A HUE028713T2 (en) 2007-04-30 2008-04-30 Treatment of virally induced lesions
BRPI0810806-4A2A BRPI0810806A2 (en) 2007-04-30 2008-04-30 METHOD FOR TREATING CUTANEOUS INJURY IN AN INDIVIDUAL
HRP20160181TT HRP20160181T1 (en) 2007-04-30 2008-04-30 TREATMENT OF VIRUSALLY INDUCED LESIONS
HK10102512.3A HK1134450B (en) 2007-04-30 2008-04-30 Treatment of virally induced lesions
NZ580702A NZ580702A (en) 2007-04-30 2008-04-30 Treatment of virally induced lesions
MYPI20094567A MY154484A (en) 2007-04-30 2008-04-30 Treatment of virally induces lesions
IL201796A IL201796A (en) 2007-04-30 2009-10-28 Indol-3-angelate or pharmaceutically acceptable salts thereof for use in the treatment of a cutaneous lesion, said lesion caused by a papilloma virus
CY20161100164T CY1119269T1 (en) 2007-04-30 2016-02-29 Virus-Caused Damage Therapy

Publications (1)

Publication Number Publication Date
AU2007902266A0 true AU2007902266A0 (en) 2007-05-17

Family

ID=

Similar Documents

Publication Publication Date Title
IL201796A0 (en) Treatment of virally induced lesions
IL248204A0 (en) Combination treatment of cd38-expressing tumors
ZA200906210B (en) 3-Imidazolyl-Indoles for the treatment of proliferative diseases
ZA200906126B (en) Use of IL-23 antigonists for treatment of infection
PL2205245T3 (en) Therapeutic use of diaminophenothiazines
EP2049139A4 (en) Treatment of ras-expressing tumors
WO2011062906A9 (en) Treatment of atrial fibriallation
ZA201000225B (en) Treatment of depression
PL2171061T3 (en) Preparation of an esterase
WO2007080149A8 (en) Treatment of stressed patients
GB0723100D0 (en) Treatment of HFnEF
AU2007902266A0 (en) Treatment of virally induced lesions
AU2007902252A0 (en) Treatment of cutaneous lesions
HK1137996A (en) 3-imidazolyl-indoles for the treatment of proliferative diseases
AU2008903504A0 (en) Treatment of Material
AU2008903089A0 (en) Treatment of Material
AU2008902966A0 (en) Treatment of Material
AU2006905417A0 (en) Treatment of infectious diseases
HK1172319A (en) Therapeutic aryl-am i do-aryl compounds and their use
AU2016202705A1 (en) Treatment of synucleinopathies
HK1166856A (en) Use of cathepsin h
HK1152310A (en) Compounds for the treatment of hepatitis c
AU2008902372A0 (en) Methods of treatment
AU2008906046A0 (en) iNOS inhibition
HK1138846A (en) Compounds for the treatment of hepatitis c